Every study recruiting in India, live from the public registry.
A catalogue of ClinicalTrials.gov records with a site in India, filtered by state, condition, phase and status — and the rest of the world one chip away. Not a marketplace: a readable view of a public register.
- 608recruiting in India today
- 764open or opening soon in India
- 64,486recruiting worldwide
- The registry’s own counts, refreshed hourly.
Showing 22 of 608 studies recruiting in India.
Public records · ClinicalTrials.gov · recently updated first
- Phase 3RecruitingStarted May 2024
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Ahmedabad, Kozhikode, Kolhāpur, Nagpur +7 more
SponsorNovartis Pharmaceuticals11sites in India - Phase 2RecruitingStarted Aug 2022
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Kozhikode, New Delhi, Hyderabad, Lucknow
SponsorNovartis Pharmaceuticals4sites in India - Phase 3RecruitingStarted Sep 2026
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Epithelial Ovarian Cancer
Ansārinagar, Bhubaneswar, Hyderabad, Mumbai +6 more
SponsorAstraZeneca10sites in India - Phase 1RecruitingStarted Feb 2026
A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis
Rheumatoid Arthritis
Hyderabad, Ahmedabad, Bangalore, Mysuru +4 more
SponsorBristol-Myers Squibb8sites in India - Phase 2RecruitingStarted Apr 2026
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Kochi, Kolkata, Maharashtra, New Delhi
SponsorBoehringer Ingelheim4sites in India - Phase 3RecruitingStarted Jun 2024
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Aurangabad, Bangalore, Bengaluru, Bikaner +10 more
SponsorBoehringer Ingelheim14sites in India - Phase 3RecruitingStarted May 2026
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Primary Myelofibrosis (PMF) · Post-polycythemia Vera Myelofibrosis (PPV-MF) · Post-essential Thrombocythemia Myelofibrosis (PET-MF)
Aurangabad, Pune, Rishikesh, Kolkata +1 more
SponsorNovartis Pharmaceuticals5sites in India - Phase 3RecruitingStarted Sep 2026
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Myelofibrosis · Anemia
Gurgaon, Kochi, Thiruvananthapuram, Pune +6 more
SponsorTakeda10sites in India - Phase not statedRecruitingStarted Feb 2026
The International Spinal Cord Injury Blood Biomarker Longitudinal Evaluation (I-SCRIBBLE) Study
Spinal Cord Injury
New Delhi
SponsorAO Foundation, AO Spine1site in India - Phase not statedRecruitingStarted Mar 2025
Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions
Spinal Fusion
Kolkata
SponsorAO Foundation, AO Spine1site in India - Phase 3RecruitingStarted May 2025
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Aurangabad, Bangalore, Bikaner, Chennai +10 more
SponsorBoehringer Ingelheim14sites in India - Phase 3RecruitingStarted Jul 2024
Parasitic Ulcer Treatment Trial
Acanthamoeba Keratitis
Coimbatore, Madurai
SponsorJeremy Keenan, MD, MPH2sites in India - Phase 3RecruitingStarted Oct 2024
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic Dysfunction Associated Steatohepatitis (MASH) · Liver Fibrosis
Ahemdabad, Chandigarh, Hyderabad, Afzalgunj, Jaipur +11 more
SponsorBoehringer Ingelheim15sites in India - Phase 3RecruitingStarted Nov 2024
An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older
Malaria, Vivax
Ahmedabad, Bikaner, Kolkata, Mumbai +1 more
SponsorGlaxoSmithKline5sites in India - Phase 3RecruitingStarted Nov 2024
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis
Ahemdabad, Chandigarh, Hyderabad, Afzalgunj, Jaipur +8 more
SponsorBoehringer Ingelheim12sites in India - Phase 3RecruitingStarted Aug 2026
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Type 2 Diabetes
Ahmedabad, Bhubaneswar, Cuttack, Hyderabad, Afzalgunj +9 more
SponsorBoehringer Ingelheim13sites in India - Phase 3RecruitingStarted Feb 2026
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Ahmedabad, Bhubaneswar, Bikaner, Chennai +15 more
SponsorBoehringer Ingelheim19sites in India - Phase 3RecruitingStarted Jan 2026
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Overweight · Obesity
Guntur, Surat, Bangalore, New Delhi +5 more
SponsorNovo Nordisk A/S9sites in India - Phase 3RecruitingStarted Dec 2023
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Bengaluru, Hyderabad, Kanpur, Kolkata +6 more
SponsorAstraZeneca10sites in India - Phase 3RecruitingStarted Jul 2025
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2 · Hypertension · Cardiovascular Diseases
Sāket
SponsorBoehringer Ingelheim1site in India - Phase 3RecruitingStarted Mar 2026
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Non-small Cell Lung Cancer (NSCLC)
Eluru, Goraj, Pūlakkōd, Aurangabad +8 more
SponsorBristol-Myers Squibb12sites in India - Phase 3RecruitingStarted May 2025
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Immunoglobulin A Nephropathy (IgAN)
Hyderabad, Raipur, Ahmedabad, Nadiād +10 more
SponsorBiogen14sites in India
Every study above is a public record from ClinicalTrials.gov, run by the sponsor and sites named on it. Trialion does not run these studies, cannot enrol anyone, and is not paid for referrals. Studies registered only with CTRI are not included. Site counts leave out sites the record marks as suspended or closed. A location filter finds records where the site typed that place in, so a study can be running near you and not appear here.
A public register, made readable.
- Public records, liveEvery card is a ClinicalTrials.gov entry, fetched from the registry and refreshed every fifteen minutes. Nothing is typed in by hand.
- Not our studiesTrialion does not run them, cannot enrol anyone, and is not paid for referrals. The sponsor and the sites are named on every record.
- Take the number to a doctorAn NCT number links back to the registry entry with its sites and ethics approvals. A doctor can say whether a study is worth approaching.
The data behind a study belongs on one record.
The EDC drafts the forms from your protocol, reads the lab reports, and holds every change on one audit trail. Bring the protocol and see it running.
